Does BOSUTINIB Cause Interstitial lung disease? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Interstitial lung disease have been filed in association with BOSUTINIB (BOSULIF). This represents 0.4% of all adverse event reports for BOSUTINIB.
31
Reports of Interstitial lung disease with BOSUTINIB
0.4%
of all BOSUTINIB reports
4
Deaths
20
Hospitalizations
How Dangerous Is Interstitial lung disease From BOSUTINIB?
Of the 31 reports, 4 (12.9%) resulted in death, 20 (64.5%) required hospitalization, and 1 (3.2%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for BOSUTINIB.
What Other Side Effects Does BOSUTINIB Cause?
Diarrhoea (1,820)
Nausea (886)
Fatigue (626)
Vomiting (469)
Death (465)
Rash (426)
Pleural effusion (398)
Neoplasm progression (376)
Dyspnoea (319)
Headache (283)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BOSUTINIB Alternatives Have Lower Interstitial lung disease Risk?
BOSUTINIB vs BOTOX
BOSUTINIB vs BOTOX COSMETIC
BOSUTINIB vs BOTULINUM TOXIN NOS
BOSUTINIB vs BOTULINUM TOXIN TYPE A
BOSUTINIB vs BREMELANOTIDE